<?xml version="1.0" encoding="UTF-8"?>
<ref id="B145-pharmaceutics-12-00688">
 <label>145.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fehrholz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Glaser</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Seidenspinner</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ottensmeier</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Curstedt</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Speer</surname>
    <given-names>C.P.</given-names>
   </name>
   <name>
    <surname>Kunzmann</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes</article-title>
  <source>PLoS ONE</source>
  <year>2016</year>
  <volume>11</volume>
  <elocation-id>e0153578</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0153578</pub-id>
  <?supplied-pmid 27077658?>
  <pub-id pub-id-type="pmid">27077658</pub-id>
 </element-citation>
</ref>
